Concepedia

Chirag Acharya

CA

21

Publications

2.7K

Citations

17

H-Index

2012

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Institute of Hematology & Blood Diseases Hospital

Harvard University

Ospedale Policlinico San Martino

University of Genoa

Chirag Acharya is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

2012–2021

21

Publications

21

Novel anti–B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma

Yu‐Tzu Tai, Patrick A. Mayes, Chirag Acharya et al. · Blood · 2014 · 472 citations

APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment

Yu‐Tzu Tai, Chirag Acharya, Gang An et al. · Blood · 2016 · 347 citations · Full text

CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications

Y-T Tai, Yosef Landesman, Chirag Acharya et al. · Leukemia · 2013 · 299 citations · Full text

, , +10

Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple Myeloma

Xiaoyan Feng, Li Zhang, Chirag Acharya et al. · Clinical Cancer Research · 2017 · 239 citations · Full text

RETRACTED ARTICLE: SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide

Hua Jiang, Chirag Acharya, Gary An et al. · Leukemia · 2015 · 220 citations

Rows per page

1–5 of 21